HK1212218A1 - Organoarsenic compounds and methods for the treatment of cancer - Google Patents

Organoarsenic compounds and methods for the treatment of cancer Download PDF

Info

Publication number
HK1212218A1
HK1212218A1 HK16100117.0A HK16100117A HK1212218A1 HK 1212218 A1 HK1212218 A1 HK 1212218A1 HK 16100117 A HK16100117 A HK 16100117A HK 1212218 A1 HK1212218 A1 HK 1212218A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
lymphoma
hours
compound
aralkyl
Prior art date
Application number
HK16100117.0A
Other languages
English (en)
Chinese (zh)
Inventor
．施沃茨
B．E．施沃茨
．劉易斯
J.刘易斯
．科馬尼特斯基
P．B．科马尼特斯基
Original Assignee
日本苏爱康制药有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本苏爱康制药有限公司 filed Critical 日本苏爱康制药有限公司
Publication of HK1212218A1 publication Critical patent/HK1212218A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK16100117.0A 2008-08-20 2016-01-07 Organoarsenic compounds and methods for the treatment of cancer HK1212218A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18951108P 2008-08-20 2008-08-20
US61/189,511 2008-08-20

Publications (1)

Publication Number Publication Date
HK1212218A1 true HK1212218A1 (en) 2016-06-10

Family

ID=41707414

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100117.0A HK1212218A1 (en) 2008-08-20 2016-01-07 Organoarsenic compounds and methods for the treatment of cancer

Country Status (19)

Country Link
US (4) US20110269697A1 (enExample)
EP (2) EP3388111B1 (enExample)
JP (5) JP5933896B2 (enExample)
KR (3) KR20180103194A (enExample)
CN (2) CN104800828A (enExample)
AU (1) AU2009282972A1 (enExample)
BR (1) BRPI0918407A2 (enExample)
CA (1) CA2734650A1 (enExample)
DK (2) DK3388111T3 (enExample)
ES (2) ES2901426T3 (enExample)
HK (1) HK1212218A1 (enExample)
IL (1) IL211153A0 (enExample)
MX (1) MX2011001800A (enExample)
NZ (1) NZ591181A (enExample)
PT (2) PT3388111T (enExample)
RU (1) RU2534606C2 (enExample)
SG (3) SG10201810449XA (enExample)
WO (1) WO2010021928A1 (enExample)
ZA (1) ZA201101216B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015085208A1 (en) * 2013-12-05 2015-06-11 Solasia Pharma K.K. Compounds and methods for the treatment of cancer
CN104151397A (zh) * 2014-07-03 2014-11-19 北京大学 一类新型三硫杂二环有机砷化物及其合成方法和在抗肿瘤领域里的应用
JP6413969B2 (ja) * 2015-07-29 2018-10-31 住友金属鉱山株式会社 日射遮蔽体形成用分散液および当該分散液を用いた日射遮蔽体
WO2019220961A1 (ja) * 2018-05-18 2019-11-21 ソレイジア・ファーマ株式会社 ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
CN113408945B (zh) * 2021-07-15 2023-03-24 广西中烟工业有限责任公司 一种烤烟纯度的检测方法、装置、电子设备及存储介质

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234972A (en) 1880-11-30 William ennis
US761900A (en) 1904-03-05 1904-06-07 Newton Jefferson Norman Flux compound.
US2349729A (en) 1940-08-24 1944-05-23 Parke Davis & Co Therapeutic arsenic preparation
DK1391206T3 (da) 1997-10-15 2008-09-01 Polarx Biopharmaceuticals Inc Farmaceutiske præparater der omfatter arsentrioxyd til behandling af ikke-Hodgkins lymfom
CA2309652C (en) 1997-11-10 2013-01-29 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
CN1233476A (zh) 1998-04-24 1999-11-03 陆道培 治疗急性白血病的药物及其制备方法
EP1002537A1 (en) 1998-10-30 2000-05-24 Assistance Publique, Hopitaux De Paris Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma
US6191123B1 (en) 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
WO2001080832A2 (en) 2000-04-26 2001-11-01 Oregon Health Sciences University Administration of a thiol-based chemoprotectant compound
DE10132625A1 (de) 2001-07-05 2003-01-23 Oce Printing Systems Gmbh Verfahren, Computerprogrammprodukt und Gerätesystem zum visuellen Überprüfen von Bilddaten
EP2420229A1 (en) 2002-01-07 2012-02-22 Board Of Regents, University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
TW201440760A (zh) 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
EP1919564B1 (en) 2005-07-29 2014-11-26 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
CN104109177A (zh) * 2006-01-13 2014-10-22 得克萨斯州A&M大学系统 用于治疗癌症的化合物和方法
TW200829261A (en) 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
CA2694983A1 (en) * 2007-07-17 2009-01-22 Combinatorx, Incorporated Treatments of b-cell proliferative disorders
TW200914048A (en) * 2007-07-17 2009-04-01 Combinatorx Inc Combinations for the treatment of B-cell proliferative disorders
JP2011502985A (ja) * 2007-11-02 2011-01-27 ジオファーム オンコロジー， インコーポレイテッド 有機ヒ素剤を使用する併用療法
US20100009934A1 (en) * 2008-06-09 2010-01-14 Combinatorx, Incorporated Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders

Also Published As

Publication number Publication date
NZ591181A (en) 2012-09-28
JP2015120755A (ja) 2015-07-02
EP2321012B1 (en) 2018-10-10
RU2534606C2 (ru) 2014-11-27
US20210038556A1 (en) 2021-02-11
IL211153A0 (en) 2011-04-28
BRPI0918407A2 (pt) 2015-11-24
ES2901426T3 (es) 2022-03-22
JP2017002081A (ja) 2017-01-05
JP6315841B2 (ja) 2018-04-25
US11324714B2 (en) 2022-05-10
EP3388111A1 (en) 2018-10-17
KR20170103023A (ko) 2017-09-12
MX2011001800A (es) 2011-04-04
US11324713B2 (en) 2022-05-10
AU2009282972A1 (en) 2010-02-25
CA2734650A1 (en) 2010-02-25
US10842769B2 (en) 2020-11-24
US20110269697A1 (en) 2011-11-03
WO2010021928A1 (en) 2010-02-25
US20210038557A1 (en) 2021-02-11
PT3388111T (pt) 2021-12-23
HK1254607A1 (en) 2019-07-26
EP2321012A4 (en) 2011-10-05
PT2321012T (pt) 2019-01-11
JP5933896B2 (ja) 2016-06-15
ZA201101216B (en) 2011-10-26
JP2012500271A (ja) 2012-01-05
US20150231107A1 (en) 2015-08-20
JP5976036B2 (ja) 2016-08-23
DK3388111T3 (da) 2021-12-06
CN104800828A (zh) 2015-07-29
KR20180103194A (ko) 2018-09-18
KR20110058818A (ko) 2011-06-01
JP2014148552A (ja) 2014-08-21
DK2321012T3 (en) 2018-12-03
JP2018039853A (ja) 2018-03-15
ES2703740T3 (es) 2019-03-12
CN102149432A (zh) 2011-08-10
EP3388111B1 (en) 2021-09-29
SG10201810449XA (en) 2018-12-28
RU2011110392A (ru) 2012-09-27
EP2321012A1 (en) 2011-05-18
SG10201810450QA (en) 2018-12-28
SG10201403869TA (en) 2014-10-30

Similar Documents

Publication Publication Date Title
US11324714B2 (en) Organoarsenic compounds and methods for the treatment of cancer
JP5745660B2 (ja) 癌の治療のための化合物および方法
JP2009502971A (ja) がんを治療するための化合物および方法
HK1157694B (en) Organoarsenic compounds and methods for the treatment of cancer
HK1157694A (en) Organoarsenic compounds and methods for the treatment of cancer
HK1254607B (en) Organoarsenic compound for the treatment of cancer
AU2011204901B2 (en) Compounds and methods for treatment of cancer